1. Home
  2. SILO vs GITS Comparison

SILO vs GITS Comparison

Compare SILO & GITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • GITS
  • Stock Information
  • Founded
  • SILO 2010
  • GITS 2018
  • Country
  • SILO United States
  • GITS South Korea
  • Employees
  • SILO N/A
  • GITS N/A
  • Industry
  • SILO Apparel
  • GITS
  • Sector
  • SILO Consumer Discretionary
  • GITS
  • Exchange
  • SILO Nasdaq
  • GITS Nasdaq
  • Market Cap
  • SILO 5.9M
  • GITS 7.0M
  • IPO Year
  • SILO N/A
  • GITS N/A
  • Fundamental
  • Price
  • SILO $0.68
  • GITS $2.63
  • Analyst Decision
  • SILO
  • GITS
  • Analyst Count
  • SILO 0
  • GITS 0
  • Target Price
  • SILO N/A
  • GITS N/A
  • AVG Volume (30 Days)
  • SILO 289.1K
  • GITS 25.8K
  • Earning Date
  • SILO 08-13-2025
  • GITS 10-14-2025
  • Dividend Yield
  • SILO N/A
  • GITS N/A
  • EPS Growth
  • SILO N/A
  • GITS N/A
  • EPS
  • SILO N/A
  • GITS N/A
  • Revenue
  • SILO $72,102.00
  • GITS $29.00
  • Revenue This Year
  • SILO $1.86
  • GITS N/A
  • Revenue Next Year
  • SILO N/A
  • GITS N/A
  • P/E Ratio
  • SILO N/A
  • GITS N/A
  • Revenue Growth
  • SILO N/A
  • GITS N/A
  • 52 Week Low
  • SILO $0.41
  • GITS $0.87
  • 52 Week High
  • SILO $3.37
  • GITS $9.78
  • Technical
  • Relative Strength Index (RSI)
  • SILO 55.60
  • GITS 62.58
  • Support Level
  • SILO $0.58
  • GITS $2.02
  • Resistance Level
  • SILO $0.65
  • GITS $2.33
  • Average True Range (ATR)
  • SILO 0.04
  • GITS 0.15
  • MACD
  • SILO 0.00
  • GITS 0.04
  • Stochastic Oscillator
  • SILO 83.31
  • GITS 95.31

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About GITS Global Interactive Technologies Inc. Common Stock

Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.

Share on Social Networks: